Form 8-K - Current report:
SEC Accession No. 0001390478-17-000027
Filing Date
2017-04-03
Accepted
2017-04-03 17:25:12
Documents
2
Period of Report
2017-04-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K gale-201704038xk.htm 8-K 40374
2 EXHIBIT 10.1 gale-20170403ex101.htm EX-10.1 24537
  Complete submission text file 0001390478-17-000027.txt   66348
Mailing Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239
Business Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239 855 855 GALE
Galena Biopharma, Inc. (Filer) CIK: 0001390478 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33958 | Film No.: 17735351
SIC: 2834 Pharmaceutical Preparations